Moleculin Biotech, Inc. (MBRX)

NASDAQ: MBRX · IEX Real-Time Price · USD

4.315

-0.155 (-3.47%)

At close: Jul 19, 2024, 12:00 AM

4.310

-0.005 (-0.12%)

Pre-market: Jul 22, 2024, 8:12 AM EDT

Moleculin Biotech Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2014
Net Income	-26.82	-29.77	-29.03	-15.89	-17.36	-13.21	Upgrade
Depreciation & Amortization	0.13	0.13	0.13	0.16	0.2	0.2	Upgrade
Share-Based Compensation	1.98	1.98	2.28	2.37	1.68	1.54	Upgrade
Other Operating Activities	-0.08	3.56	-1.02	-5.59	-2.3	-5.73	Upgrade
Operating Cash Flow	-24.8	-24.1	-27.64	-18.95	-17.77	-17.2	Upgrade
Capital Expenditures	-0.12	-0.12	-0.07	-0.02	-0.37	-0.05	Upgrade
Investing Cash Flow	-0.12	-0.12	-0.07	-0.02	-0.37	-0.05	Upgrade
Share Issuance / Repurchase	4.03	4.17	0	74.75	22.57	20.85	Upgrade
Other Financing Activities	0.49	0.49	-0.02	-0.02	-0.02	-	Upgrade
Financing Cash Flow	4.51	4.65	-0.02	74.72	22.55	20.85	Upgrade
Exchange Rate Effect	-0.03	-0.02	-0.03	-0.02	0.03	-0	Upgrade
Net Cash Flow	-20.44	-19.6	-27.76	55.73	4.44	3.6	Upgrade
Free Cash Flow	-24.93	-24.23	-27.71	-18.97	-18.15	-17.25	Upgrade
Free Cash Flow Per Share	-10.11	-12.26	-14.53	-10.59	-27.64	-38.12	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).